Strategic Partnerships Gentuity has active collaboration and distribution momentum with GE Healthcare and Nipro Medical Corporation, indicating a proven pathway for channel partnerships and OEM collaborations to expand market reach and accelerate adoption of their intravascular imaging platform.

Clinical Target The company focuses on next-generation intravascular imaging and Total Vessel Imaging with a 1.8F micro-imaging catheter, aligning with cardiovascular centers and interventional labs seeking advanced imaging to improve procedural guidance and outcomes.

Market Readiness Participation in major conferences such as Transcatheter Cardiovascular Therapeutics (TCT) signals active market engagement, early adopter interest, and opportunities to generate priority pilot programs and case studies with leading interventional cardiology groups.

Growth Potential Revenue range of 10–25 million with a 51–200 employee base suggests a scaling stage where targeted outreach to mid to large cardiovascular centers, hospitals, and regional distributors could yield high-value sales cycles and strategic large-volume deals.

Technology Advantage Integration of AI and machine learning for collaborative intelligence in imaging positions Gentuity to offer differentiating value propositions such as enhanced ease of use, vendor-neutral data capabilities, and potential upsell opportunities for analytics and decision-support modules.